Can liver stiffness predict cancer return after ablation?
Part of Cancer, Digestive system clinical trials.
This trial studies if measuring liver and spleen stiffness can help predict the risk of liver cancer coming back after radiofrequency ablation (RFA), a treatment that uses heat to destroy tumors. It aims to improve follow-up care for people with chronic liver disease and early-stage liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic liver disease (such as cirrhosis).
- Your liver cancer is being treated with radiofrequency ablation (RFA).
- You are willing to have a special ultrasound to measure stiffness in your liver and spleen.
- You are 18 years or older.
- You have not had a liver transplant or major liver surgery for cancer in the last two years.
- Your liver disease is stable (not decompensated or Child-Pugh class C).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
This study tests new criteria for evaluating how well thermal ablation (using heat to destroy cancer nodules) worked in people with hepatocellular carcinoma (HCC, a type of liver cancer). It aims to improve follow-up imaging with contrast-enhanced ultrasound (CEUS) or CT/MRI to see if the treatment was successful.
This study looks at whether using radiofrequency (a heat-based treatment used during surgery) during liver surgery can lower the chances that cancer returns locally. It includes people with colorectal cancer that has spread to the liver and people with liver cancer (HCC).
This study compares two ways to treat liver cancer that has come back after surgery: a keyhole operation (laparoscopic surgery) to remove the tumor, or a procedure that uses heat to destroy it (radiofrequency ablation). The goal is to see which approach is better for people with small, limited recurrences.
This trial is testing whether a procedure called radiofrequency ablation (using heat to destroy tumors) is safe and effective for people whose colorectal cancer has spread to the liver and come back there. It might help if you have a few small liver tumors that cannot be removed with surgery.
This study looks at whether a special MRI scan after liver surgery can help predict if the cancer might come back. By measuring the stiffness of the tissue around the tumor, doctors hope to identify patients who may need closer monitoring.
Hear when a new HCC - Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.